课题基金 / 基金详情

项目摘要

项目成果

Frederic Barr的其他基金

相似基金

相关文献

中文摘要
翻译
在以前的研究中,我们构建了多西环素可诱导的PAX3-FOXO1表达结构,并将该结构引入永生化的人成肌细胞(有和没有结构性MYCN表达结构)。在所形成的细胞培养系统中,PAX3-FOXO1的表达可以被多西环素处理上调,然后被多西环素停用而下调。在细胞培养研究中,转导MYCN和PAX3-FOXO1的成肌细胞在病灶形成实验中显示出高水平的致癌转化,而未转导多西环素或仅转导PAX3-FOXO1或MYCN的细胞则未检测到转化。当在转导MYCN和可诱导的PAX3-FOXO1构建的细胞的病灶形成过程中去除强力霉素时,形成了较小的病灶,并伴有明显的肌源性分化和细胞死亡。为了在体内研究这些致癌事件,将这些细胞肌肉注射给小鼠,当小鼠喂食添加多西环素的饲料时,PAX3-FOXO1诱导的成肌细胞形成渐进性生长的肿瘤;同时表达PAX3-FOXO1和MYCN的细胞形成快速生长的肿瘤,而表达PAX3-FOXO1的细胞几周后形成肿瘤。所有肿瘤的组织学形态与人类手臂相似,MyoD和Mygenin高表达。频繁的有丝分裂和高Ki67染色指数表明高增殖率。为了确定在这些肿瘤中持续表达PAX3-FOXO1的必要性,在可触及的小肿瘤形成后停用多西环素,导致肿瘤停止生长并退化到检测不到的水平。表达研究证实,PAX3-FOXO1的mRNA和蛋白水平急剧下降,退行性肿瘤的显微镜检查显示,细胞增殖一过性下降,与广泛的肌源性分化和细胞死亡有关。在这些动物研究中,肿瘤消退后,尽管继续缺乏诱导剂,肿瘤通常在几周后复发。对复发肿瘤样本的分析显示,在超过一半的复发肿瘤中没有检测到PAX3-FOXO1的表达。接下来,从原发和复发肿瘤中培养出细胞系,以进一步研究这些致癌效应。表达外源PAX3-FOXO1和MYCN的原代肿瘤细胞系表现出PAX3-FOXO1依赖的转化和肿瘤形成,与原始转导的亲本群体相似。相反,只表达外源PAX3-FOXO1的原代肿瘤细胞系在培养中转化,形成肿瘤的速度比最初转导的亲本群体快得多,这与肿瘤形成过程中依赖PAX3-FOXO1的转化变异体的选择一致。对不表达融合蛋白的复发肿瘤细胞系的研究显示,在没有多西环素的情况下,转化和肿瘤形成与获得额外的致癌事件一致,这些事件使这些细胞独立于融合蛋白。与原始转导亲本细胞的原代肿瘤细胞系或亚克隆相似的复发形成为这种复发现象的普遍性提供了证据。最后,虽然来自原发肿瘤的细胞系依赖于PAX3-FOXO1,并在去掉多西环素后分化,但复发的肿瘤来源细胞在这些条件下没有分化,而是持续增殖,与PAX3-FOXO1不依赖的分化阻滞一致。
英文摘要
In previous studies, we constructed a doxycycline-inducible PAX3-FOXO1 expression construct and introduced this construct into immortalized human myoblasts (with and without a constitutive MYCN expression construct). In the resulting cell culture system, PAX3-FOXO1 expression can be up-regulated by doxycycline treatment and then down-regulated by doxycycline withdrawal. In cell culture studies, doxycycline-treated myoblasts transduced with MYCN and PAX3-FOXO1 showed a high level of oncogenic transformation in a focus formation assay whereas there was no transformation detected without doxycycline treatment or in cells transduced only with PAX3-FOXO1 or MYCN. When doxycycline was removed during the course of the focus formation assay of cells transduced with MYCN and inducible PAX3-FOXO1 constructs, smaller foci formed with prominent myogenic differentiation and cell death. To study these oncogenic events in vivo, mice were injected intramuscularly with these cells, and progressively growing tumors formed from PAX3-FOXO1-inducible myoblasts when the mice were fed a doxycycline-supplemented diet; cells expressing both PAX3-FOXO1 and MYCN formed rapidly growing tumors whereas cells expressing PAX3-FOXO1 without exogenous MYCN formed tumors several weeks later. All tumors showed histologic resemblance to human ARMS with high expression of MyoD and myogenin. Frequent mitoses and a high Ki67 staining index were indicative of a high proliferative rate. To determine the requirement for continued PAX3-FOXO1 expression in these tumors, doxycycline was withdrawn after small palpable tumors formed, resulting in a cessation of tumor growth and regression to undetectable levels. Expression studies confirmed that PAX3-FOXO1 mRNA and protein levels drastically decreased, and microscopic examination of regressing tumors revealed a transient decrease in cellular proliferation in association with widespread myogenic differentiation and cell death. Following tumor regression in these animal studies, tumors generally recurred several weeks later despite the continued absence of inducing agent. Analysis of recurrent tumor samples revealed that there was no detectable PAX3-FOXO1 expression in more than half of these recurrent tumors. Cell lines were next generated from primary and recurrent tumors to further investigate these oncogenic effects. Primary tumor-derived lines expressing exogenous PAX3-FOXO1 and MYCN demonstrated PAX3-FOXO1-dependent transformation and tumorigenesis similar to the original transduced parental population. In contrast, primary tumor-derived lines expressing only exogenous PAX3-FOXO1 were transformed in culture and formed tumors at a much faster rate than the original transduced parental population, consistent with the selection of PAX3-FOXO1-dependent transformed variants during tumorigenesis. Studies of cell lines derived from recurrent tumors that did not express the fusion protein revealed transformation and tumorigenesis, both in the absence of doxycycline, consistent with the acquisition of additional oncogenic events that render these cells independent of the fusion protein. The formation of similar recurrences with the primary tumor-derived cell lines or subclones of the original transduced parental cells provided evidence of the generality of this recurrence phenomenon. Finally, though cell lines derived from primary tumors were dependent on PAX3-FOXO1 and differentiated when doxycycline was removed, the recurrent tumor-derived cells did not differentiate under these conditions and instead proliferated continuously, consistent with a PAX3-FOXO1-independent block in differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies of gene fusions in rhabdomyosarcoma
  • 批准号:
    10486830
  • 项目类别:
  • 资助金额:
    $70.45万
  • 财政年份:
    --
  • 负责人:
    Frederic Barr
  • 依托单位:
Studies of amplification in rhabdomyosarcoma
Studies of amplification in rhabdomyosarcoma
Clinical Operations for Laboratory of Pathology
海外基金